Primary Cerebral Venous Thrombosis in Young Adults:The Diverse Mmanifestations of an Underrecognized Disease
Ann Neurol 3:81, Averbak,P., 1978
Optimal Timing of Anticoagulation after Acute Ischaemic Stroke with Atrial Fibrillation (OPTIMAS): A Multicentre, Blinded-Endpoint, Phase 4, Randomised Controlled Trial
Lancet 404:1731-1741, Werring,D.J.,et al, 2024
Perioperative Management of Anticoagulant and Antiplatelet Therapy
NEJM Evid doi:10.1056/EVIDna2200322, Douketis,J.D. & Spyropoulos,A.C., 2023
MT in Anticoagulated Patients
Neurol 94: e842-e850, LAllinec, V.,et al, 2020
Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events with Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients with Atrial Fibrillation with a History of Intracranial Hemorrhage
JAMA Network Open 3:e206424, Tsai, C.T.,et al, 2020
Andexxa-An Antidote for Apixaban and Rivaroxaban
JAMA 320:399-400, , 2018
Anticoagulant-Associated Intracranial Hemorrhage in the Era of Reversal Agents
Stroke 48:1432-1437, Steiner, T.,et al, 2017
Outcome of Intracerebral Hemorrhage Associated with Different Oral Anticoagulants
Neurol 88:1693-1700,1686, Wilson, D.,et al, 2017
Early Clinical and Radiological Course, Management, and Outcome of Intracerebral Hemorrhage Related to New Oral Anticoagulants
JAMA Neurol 73:169-177,155, Purrucker, J.C.,et al, 2016
Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: Current Status, Special Situations, and Unmet Needs
Lancet 386:303-310, Verheugt, F.W.A. & Granger, C.B., 2015
Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity
NEJM 373:2413-2424,2471, Siegal, D.M.,et al, 2015
Cerebral Amyloid Angiopathy
UpToDate: May 2010, Greenberg,S.M.,et al, 2010
Intracerebral Haemorrhage
Lancet 373:1632-1644, Qureshi,A.I.,et al, 2009
Low Molecular Wt Heparinoid
ORG 10172 (Danaparoid) , & Outcome After Acute Ischemic Stroke, 10172 Acute Stroke Trtm (TOAST) Inve, t, JAMA 1272,1304,1998., 1998
Intracerebral Hemorrhage
Stroke 22:684-691, Feldmann,E., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Natural History of Progressive Ischemic Stroke in a Population Treated with Heparin
Stroke 21:1657-1662, Slivka,A.&Levy,D., 1990
An Alternative View of Heparin Anticoagulation in Acute Focal Brain Ischemia
Stroke 20:295-298, Phillips,S.J., 1989
Cholesterol Embolism:Experience with 22 Histologically Proven Cases
Surgery 105:737-746, Dahlberg,P.J.,et al, 1989
Cholesterol Crystal Embolization:A Review of 221 Cases in the English Literature
Angiology 38:769-784, Fine,M.J.,et al, 1987
Treatment of Acute Ischemic Stroke, Open Trial with Continuous Intravenous Heparinization
Arch Neurol 43:386-390, Ramirez-Lassepas,M.,et al, 1986
Cholesterol Embolism as a Cause of Transient Ischemic Attacks & Cerebral Infarction
Neurol 31:860-865, Beal,M.F.,et al, 1981
Evaluation of Acute Cerebral Ischemia for Anticoag Therapy:CT or Lumbar Puncture
Neurol 31:736-740, Ruff,R.L.,et al, 1981
Maternal & Fetal Sequelae of Anticoagulation During Pregnancy
Am J Med 68:122-140, Hall,J.G.,et al, 1980
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977